Skip Navigation Links

Posters

OHDSI 2025

Ajmal, A., Bouisson, O., Brash, J., Cheeseman, S., Banduge, P. G., Gomes, A. L., Revie, L., Ross, E., Theophanous, S., Thonnard, J., Maanen, A. V., Vengadeswaran, A., Wolf, A., & Fernández, X. (2025, July 7).
The Minimal Essential Description of Cancer (MEDOC) facilitates high-quality Real-World Evidence across a European cancer network [Poster presentation].
6th European OHDSI Symposium, Hasselt, Belgium

OHDSI 2025

Fernández, X., Revie, L., Yeap, J., Brash, J., Kaczmarczyk, I., & Anderson, J. (2025, July 7).
"Studyathons" can catalyse rapid progress in OMOP-enabled oncology research: insights from DigiONE [Poster presentation].
6th European OHDSI Symposium, Hasselt, Belgium

EACR 2025

Traverso, A., Pahlavan, G., Fernández, X., Mahon, P., & Tonon, G. (2025, June 16-19).
Building precision oncology via real-world data standardization, privacy preserving infrastructures, and collaboration among IT and clinical experts: The DIGICORE experience [Poster presentation].
European Association for Cancer Research (EACR) 2025 Congress, Lisbon, Portugal.

OHDSI 2024

Clinically validated line of therapy (LoT) algorithm for patients with metastatic non-small cell lung cancer (mNSCLC) can be implemented using systemic anti-cancer therapy (SACT) in Observational Medical Outcomes Partnership (OMOP) database

OHDSI 2024

Harmonization of routine care data from hospitals in the Digital Oncology Network for Europe (DigiONE) into Observational Medical Outcomes Partnership (OMOP) databases reveals changes in the number of new primary cancers diagnosed and 12-month survival during COVID-19 lockdowns

ESMO 2024

Federated analysis of overall survival (OS) by location of metastasis in patients with metastatic non-small cell lung cancer (mNSCLC) from the Digital Oncology Network for Europe (DigiONE)